Development of cause-specific estimates for sleep apnea and allergic rhinitis and sinusitis can be considered in the next cycles of the GBD, given their high prevalence.51,52 Lastly, reconsidering the available evidence for risk–outcome pairs would be crucial in future iterations, especially for ...